+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Formulation Development Outsourcing Market - Global Forecast 2026-2032- Product Image
Formulation Development Outsourcing Market - Global Forecast 2026-2032- Product Image
New

Formulation Development Outsourcing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666113
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global formulation development outsourcing market is evolving rapidly as pharmaceutical sponsors increasingly seek external expertise to control risk, shorten timelines, and manage complex drug development requirements.

Market Snapshot: Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market grew from USD 48.11 billion in 2025 to USD 52.89 billion in 2026, with expectations to reach USD 95.24 billion by 2032 at a CAGR of 10.24%. This upward trajectory is driven by the demand for specialized analytical capabilities, evolving drug modalities, and the essential role of contract development partners in supporting both clinical progression and regulatory compliance.

Scope & Segmentation

  • Service Types: Analytical development, formulation development, pre-formulation, stability studies, and regulatory filing support
  • Dosage-Form Specializations: Inhalation, oral liquids, oral solids, parenterals, topical, and transdermal formulations
  • Contract Models: Fixed-price, risk-sharing, and time-and-materials structures
  • Therapeutic Areas: Cardiovascular, infectious diseases, central nervous system, metabolic disorders, oncology, and biologics
  • Technology Adoption: High-resolution mass spectrometry, digital experiment platforms, AI-driven formulation screening, orthogonal impurity profiling, remote collaboration tools
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, each characterized by unique regulatory, talent, and supply chain dynamics

Key Takeaways

  • Sponsors now treat formulation development outsourcing as a strategic investment, leveraging partner expertise to future-proof clinical programs and enable downstream manufacturing success.
  • Technology advances, including digital workflows and advanced analytics, are redefining how sponsors and providers collaborate throughout the outsourcing process.
  • Specialized knowledge in biologics, cold-chain logistics, and container-closure systems has become crucial as the industry trend shifts toward complex modalities.
  • Environmental, social, and governance priorities are increasingly relevant in partner selection, with a focus on sustainability and compliant sourcing practices.
  • Contract structure flexibility—including risk-sharing and hybrid models—enables tailored partnerships that align incentives and optimize project outcomes.
  • Granular segmentation within the supplier landscape helps sponsors map their needs across analytical depth, dosage-form complexity, and therapeutic focus to address specific capability gaps.

Tariff Impact

Cumulative tariff changes through 2025 have increased input costs, altered procurement strategies, and heightened the importance of regionally diversified supply chains. Sponsors are recalibrating supplier networks and assessment criteria to mitigate tariff risk and reduce dependency on single sourcing lanes. This shift impacts excipient selection, sourcing transparency, and results in more rigorous due diligence and contract structuring to manage exposure across the development lifecycle.

Methodology & Data Sources

This analysis uses a mixed-methods approach with in-depth interviews from industry executives, scientists, and procurement leads, synthesized with secondary research on regulatory guidance and technical literature. Structured triangulation and expert validation ensure the reliability and actionable value of insights.

Why This Report Matters

  • Identify how to align outsourcing partners with evolving clinical and regulatory requirements to reduce development risk.
  • Benchmark competitive positioning and emerging best practices in technology adoption and contract structuring.
  • Strengthen supply-chain resilience and enable informed decision-making for global sourcing and program design.

Conclusion

The formulation development outsourcing sector is transitioning toward fully integrated, strategic partnerships. Success requires sponsors to prioritize technical rigor, contract flexibility, and resilient supply networks while investing in collaborative, digitally enabled operating models.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Formulation Development Outsourcing Market, by Service Type
8.1. Analytical Development
8.1.1. Method Development
8.1.2. Method Validation
8.1.3. Sample Analysis
8.2. Formulation Development
8.3. Pre Formulation
8.4. Regulatory Filing Support
8.5. Stability Studies
9. Formulation Development Outsourcing Market, by Dosage Form
9.1. Inhalation
9.2. Oral Liquid
9.3. Oral Solid
9.4. Parenteral
9.4.1. Intramuscular
9.4.2. Intravenous
9.4.3. Subcutaneous
9.5. Topical
9.5.1. Cream
9.5.2. Gel
9.5.3. Ointment
9.6. Transdermal
10. Formulation Development Outsourcing Market, by Contract Model
10.1. Fixed Price
10.2. Risk Sharing
10.3. Time And Materials
11. Formulation Development Outsourcing Market, by Therapeutic Area
11.1. Cardiovascular
11.2. Central Nervous System
11.3. Infectious Diseases
11.4. Metabolic Disorders
11.5. Oncology
12. Formulation Development Outsourcing Market, by End User
12.1. Pharmaceutical Companies
12.2. Generic Drug Companies
12.3. Animal Health Companies
12.4. Academic & Research Institutions
13. Formulation Development Outsourcing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Formulation Development Outsourcing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Formulation Development Outsourcing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Formulation Development Outsourcing Market
17. China Formulation Development Outsourcing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. AstraZeneca PLC
18.7. Bristol Myers Squibb Company
18.8. Catalent Inc.
18.9. Charles River Laboratories International, Inc.
18.10. Covance Inc.
18.11. Evotec SE
18.12. Fujifilm Holdings Corporation
18.13. GlaxoSmithKline plc
18.14. ICON plc
18.15. IQVIA Inc.
18.16. Laboratory Corporation of America Holdings
18.17. Lonza Group AG
18.18. Merck & Co., Inc.
18.19. Novartis AG
18.20. Patheon N.V.
18.21. Pfizer Inc.
18.22. PPD, LLC
18.23. Recipharm AB
18.24. Samsung Biologics Co., Ltd.
18.25. Sanofi S.A.
18.26. Syneos Health Inc.
18.27. Thermo Fisher Scientific Inc.
18.28. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENERIC DRUG COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENERIC DRUG COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENERIC DRUG COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANIMAL HEALTH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANIMAL HEALTH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANIMAL HEALTH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 146. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 147. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 148. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 150. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 151. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 163. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 164. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 165. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 166. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 167. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 168. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 169. AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 183. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 184. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 185. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 186. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 187. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 188. ASEAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 192. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 193. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 194. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 195. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 196. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 197. GCC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 210. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 211. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 212. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 213. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 214. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 215. BRICS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 218. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 219. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 220. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 221. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 222. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 223. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 224. G7 FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 227. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 228. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 229. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 230. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 231. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 232. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 233. NATO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 246. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 247. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 248. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 249. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 250. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2032 (USD MILLION)
TABLE 251. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 252. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Formulation Development Outsourcing market report include:
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • Evotec SE
  • Fujifilm Holdings Corporation
  • GlaxoSmithKline plc
  • ICON plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Patheon N.V.
  • Pfizer Inc.
  • PPD, LLC
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • Sanofi S.A.
  • Syneos Health Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 52.89 Billion
Forecasted Market Value ( USD ) by 2032 $ 95.24 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Formulation Development Outsourcing Market Report by Service, Dosage Form, Application, End User, and Region 2025-2033 - Product Image

Formulation Development Outsourcing Market Report by Service, Dosage Form, Application, End User, and Region 2025-2033

  • Report
  • 149 Pages
  • Global
From
Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology - Product Image

Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Formulation Development Outsourcing - Global Strategic Business Report - Product Image

Formulation Development Outsourcing - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 164 Pages
  • Global
From

About the Formulation Development Market

The Formulation Development market within the context of Pharmaceutical Manufacturing is a specialized sector of the industry that focuses on the development of drug formulations. This includes the process of creating a drug product that is suitable for its intended use, such as a tablet, capsule, or injectable. This process involves the selection of the active pharmaceutical ingredient, the selection of excipients, the design of the formulation, and the optimization of the manufacturing process. The goal of this process is to create a safe and effective drug product that meets the requirements of regulatory agencies. Formulation Development is a critical step in the drug development process, as it ensures that the drug product is safe and effective. It is also important for the successful commercialization of a drug product. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.